Status:
UNKNOWN
Study of Tolerance, Biodistribution and Dosimetry of Fucoidan Radiolabeled by Technetium-99m
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Healthy Volunteer
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The development of an innovative imaging agent capable of non-invasively detecting vulnerable plaques is a major objective of research in cardiovascular pathology. Such a tool would allow for better i...
Detailed Description
The development of an innovative imaging agent capable of non-invasively detecting vulnerable plaques is a major objective of research in cardiovascular pathology. Such a tool would allow for better i...
Eligibility Criteria
Inclusion
- Inclusion criteria :
- Adult volunteer
- No chronic progressive disease
- Absence of long term medication
- BMI between 18 and 35
- Absence of chronic infection by HIV, HVB, HCV
- Absence of significant biological abnormality in the screening report
- Affiliation to a social security system or CMU
- Signed informed consent
- Females with childbearing potential as well as males should use effective contraceptive methods
- Exclusion criteria :
- Pregnant or nursing woman
- Person of exclusion period of research protocol
- Person in detention by judicial or administrative decision
- Protected person (maintenance of justice, tutelage, legal guardianship)
- Person unable to express consent
Exclusion
Key Trial Info
Start Date :
February 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2018
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03422055
Start Date
February 1 2018
End Date
July 31 2018
Last Update
February 5 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Bichat - Claude Bernard
Paris, Île-de-France Region, France, 75018